ClearPath, from North American Scientific Inc. (NASI), is a multi-catheter high dose rate breast brachytherapy device. Designed to conform to the resection cavity following lumpectomy, allowing for more conformal radiation dose distribution during treatment, and to accommodate either high-dose or low-dose rate treatments, ClearPath is placed through a single incision. NASI received 510(k) marketing clearance from the FDA for a low-dose rate, or continuous release treatment using the company’s Prospera brachytherapy seeds in April 2006.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now